Published in PLoS Pathog on November 01, 2012
A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe (2014) 1.76
Influenza Virus mRNA Trafficking Through Host Nuclear Speckles. Nat Microbiol (2016) 1.41
Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J Virol (2013) 1.40
PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J Virol (2015) 1.04
The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol (2015) 1.02
Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA Biol (2013) 0.96
Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLoS Pathog (2013) 0.95
Influenza viruses and mRNA splicing: doing more with less. MBio (2014) 0.95
M2e-Based Universal Influenza A Vaccines. Vaccines (Basel) (2015) 0.93
Transport of the influenza virus genome from nucleus to nucleus. Viruses (2013) 0.91
Single-molecule FRET reveals a corkscrew RNA structure for the polymerase-bound influenza virus promoter. Proc Natl Acad Sci U S A (2014) 0.90
Determinants of virulence of influenza A virus. Eur J Clin Microbiol Infect Dis (2013) 0.89
Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol (2014) 0.88
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg (2014) 0.86
Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling the nuclear import of M1. J Virol (2013) 0.86
Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody. J Virol (2015) 0.85
Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection. J Virol (2013) 0.85
RNase L targets distinct sites in influenza A virus RNAs. J Virol (2014) 0.85
β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling. Cell Commun Signal (2014) 0.85
Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe (2014) 0.83
Computational analysis and mapping of novel open reading frames in influenza A viruses. PLoS One (2014) 0.83
Secondary structure of a conserved domain in an intron of influenza A M1 mRNA. Biochemistry (2014) 0.82
Viral and host factors required for avian H5N1 influenza A virus replication in mammalian cells. Viruses (2013) 0.82
(19)F NMR reveals multiple conformations at the dimer interface of the nonstructural protein 1 effector domain from influenza A virus. Structure (2014) 0.81
The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res (2015) 0.81
PB1-F2 attenuates virulence of highly pathogenic avian H5N1 influenza virus in chickens. PLoS One (2014) 0.80
Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus. J Virol (2015) 0.80
Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions. J Virol Methods (2013) 0.80
Crucial role of PA in virus life cycle and host adaptation of influenza A virus. Med Microbiol Immunol (2014) 0.80
Prolidase is required for early trafficking events during influenza A virus entry. J Virol (2014) 0.80
Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein. PLoS Pathog (2015) 0.80
Uncovering the Potential Pan Proteomes Encoded by Genomic Strand RNAs of Influenza A Viruses. PLoS One (2016) 0.80
Influenza Research Database: An integrated bioinformatics resource for influenza virus research. Nucleic Acids Res (2016) 0.79
Nucleocytoplasmic shuttling of influenza A virus proteins. Viruses (2015) 0.78
Insights into the roles of cyclophilin A during influenza virus infection. Viruses (2013) 0.78
Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation. J Virol (2016) 0.78
Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines. Future Virol (2015) 0.78
Origins and Evolutionary Dynamics of H3N2 Canine Influenza Virus. J Virol (2015) 0.78
Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity. J Biol Chem (2015) 0.78
Recruitment of RED-SMU1 complex by Influenza A Virus RNA polymerase to control Viral mRNA splicing. PLoS Pathog (2014) 0.78
Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines. J Virol (2016) 0.78
Interaction of NS2 with AIMP2 facilitates the switch from ubiquitination to SUMOylation of M1 in influenza A virus-infected cells. J Virol (2014) 0.78
Viral proteins that bind double-stranded RNA: countermeasures against host antiviral responses. J Interferon Cytokine Res (2014) 0.77
Characteristics of nucleocytoplasmic transport of H1N1 influenza A virus nuclear export protein. J Virol (2014) 0.77
An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro. Sci Rep (2016) 0.77
Structural features of a 3' splice site in influenza a. Biochemistry (2015) 0.76
Development and applications of single-cycle infectious influenza A virus (sciIAV). Virus Res (2015) 0.76
Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs. J Immunol (2016) 0.75
Replication-Competent Influenza A Viruses Expressing Reporter Genes. Viruses (2016) 0.75
Identification of Conserved Peptides Comprising Multiple T Cell Epitopes of Matrix 1 Protein in H1N1 Influenza Virus. Viral Immunol (2015) 0.75
Reverse Genetics Approaches for the Development of Influenza Vaccines. Int J Mol Sci (2016) 0.75
Sus scrofa miR-204 and miR-4331 Negatively Regulate Swine H1N1/2009 Influenza A Virus Replication by Targeting Viral HA and NS, Respectively. Int J Mol Sci (2017) 0.75
Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses. Virus Evol (2016) 0.75
Host cellular protein TRAPPC6AΔ interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking. J Virol (2016) 0.75
An Influenza Virus M2 Protein Specific Chimeric Antigen Receptor Modulates Influenza A/WSN/33 H1N1 Infection In Vivo. Open Virol J (2013) 0.75
PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol (2016) 0.75
Generation and Comprehensive Analysis of Host Cell Interactome of the PA Protein of the Highly Pathogenic H5N1 Avian Influenza Virus in Mammalian Cells. Front Microbiol (2017) 0.75
Phylodynamics of the emergence of influenza viruses after cross-species transmission. PLoS One (2013) 0.75
Amino Acid Residues 68-71 Contribute to Influenza A Virus PB1-F2 Protein Stability and Functions. Front Microbiol (2017) 0.75
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
Structure and mechanism of the M2 proton channel of influenza A virus. Nature (2008) 6.79
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology (1991) 4.77
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
New low-viscosity overlay medium for viral plaque assays. Virol J (2006) 3.92
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83
An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science (2012) 3.70
A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res (1991) 3.44
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J (1990) 2.93
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev (2009) 2.74
The influenza virus enigma. Cell (2009) 2.48
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res (2004) 2.43
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol (2005) 2.23
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol (2006) 2.18
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
Topology of eukaryotic type II membrane proteins: importance of N-terminal positively charged residues flanking the hydrophobic domain. Cell (1991) 2.11
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol (2007) 1.83
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. J Virol (2011) 1.52
M2e-based universal influenza A vaccine. Vaccine (2009) 1.52
Research and development of universal influenza vaccines. Microbes Infect (2010) 1.49
Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol (1992) 1.42
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity. Traffic (2006) 1.36
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res (2008) 1.30
The M2 ectodomain is important for its incorporation into influenza A virions. J Virol (1998) 1.25
The choice of alternative 5' splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc Natl Acad Sci U S A (1995) 1.23
A novel spliced transcript of influenza A/WSN/33 virus. Virus Genes (1998) 1.21
The history of avian influenza. Comp Immunol Microbiol Infect Dis (2008) 1.17
Spliced and unspliced RNAs encoded by virion RNA segment 7 of influenza virus. Nucleic Acids Res (1981) 1.11
Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Res (2011) 1.09
Influenza M2 proton channels. Biochim Biophys Acta (2010) 1.09
Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron. J Gen Virol (2005) 1.09
Relationship between the messenger RNAs transcribed from two overlapping genes of influenza virus. Nucleic Acids Res (1980) 1.06
Sequence analysis of related low-pathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989. Avian Dis (2000) 1.04
Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. J Gen Virol (1982) 1.02
The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. J Gen Virol (2011) 1.00
Transposition of domains between the M2 and HN viral membrane proteins results in polypeptides which can adopt more than one membrane orientation. J Cell Biol (1989) 1.00
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol (2010) 0.99
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus. Mol Immunol (2006) 0.98
Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J Gen Virol (2010) 0.98
The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture. J Gen Virol (2008) 0.94
Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate. J Virol (2008) 0.85
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective. J Gen Virol (2010) 0.83
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature (2005) 11.99
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
Unifying the epidemiological and evolutionary dynamics of pathogens. Science (2004) 8.33
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol (2005) 5.48
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature (2009) 4.49
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog (2008) 4.17
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med (2010) 3.91
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol (2002) 3.77
RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell (2010) 3.59
The persistent legacy of the 1918 influenza virus. N Engl J Med (2009) 3.58
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology (2003) 3.49
Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog (2008) 3.25
Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol (2004) 3.19
Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe (2010) 3.13
The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol (2003) 2.98
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
Pathology of human influenza revisited. Vaccine (2008) 2.71
Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J Virol (2004) 2.55
An overlapping essential gene in the Potyviridae. Proc Natl Acad Sci U S A (2008) 2.54
Genome packaging in influenza A virus. J Gen Virol (2009) 2.40
1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg Infect Dis (2003) 2.32
Pause on avian flu transmission research. Science (2012) 2.24
Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res (2007) 2.24
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2002) 2.21
Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol (2005) 2.19
Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res (2011) 2.16
NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol (2009) 2.16
Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem (2003) 2.15
Detection of a fourth orbivirus non-structural protein. PLoS One (2011) 2.11
Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology (2004) 2.10
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol (2003) 2.08
Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J Virol (2002) 2.05
Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis (2010) 2.03
Pandemic influenza: an inconvenient mutation. Science (2009) 2.00
Definition of the minimal viral components required for the initiation of unprimed RNA synthesis by influenza virus RNA polymerase. Nucleic Acids Res (2002) 1.98
Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J Infect Dis (2012) 1.95
Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J Virol (2006) 1.93
Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time reverse transcription-PCR. J Clin Microbiol (2009) 1.93
Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis (2010) 1.89
Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol (2007) 1.83
Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol (2009) 1.79
A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology (2002) 1.78
Engineering H5N1 avian influenza viruses to study human adaptation. Nature (2012) 1.74
User-friendly algorithms for estimating completeness and diversity in randomized protein-encoding libraries. Protein Eng (2003) 1.74
In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex. J Virol (2005) 1.73
Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir Viruses (2010) 1.68
Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc Natl Acad Sci U S A (2011) 1.67
Functional association between viral and cellular transcription during influenza virus infection. Rev Med Virol (2006) 1.65
Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65
Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1). AJR Am J Roentgenol (2009) 1.63
Homologous recombination is very rare or absent in human influenza A virus. J Virol (2008) 1.63
Dynamics of influenza virus infection and pathology. J Virol (2010) 1.62
1917 avian influenza virus sequences suggest that the 1918 pandemic virus did not acquire its hemagglutinin directly from birds. J Virol (2002) 1.60
The Rab11 pathway is required for influenza A virus budding and filament formation. J Virol (2010) 1.55
Pandemic influenza's 500th anniversary. Clin Infect Dis (2010) 1.55
Pandemic and seasonal influenza: therapeutic challenges. Drug Discov Today (2008) 1.54
Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane. Traffic (2004) 1.53
Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol (2009) 1.53
A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. J Virol (2011) 1.52
Observation of dually decoded regions of the human genome using ribosome profiling data. Genome Res (2012) 1.50
NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol (2009) 1.50
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol (2010) 1.47
Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat Biotechnol (2009) 1.47
Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. J Infect Dis (2009) 1.44
Examining the hemagglutinin subtype diversity among wild duck-origin influenza A viruses using ethanol-fixed cloacal swabs and a novel RT-PCR method. Virology (2008) 1.42
Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins. J Virol (2006) 1.42
Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses. J Virol (2015) 1.41
Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology (2008) 1.41
Pandemic influenza: certain uncertainties. Rev Med Virol (2011) 1.39
An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology (2009) 1.37
Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA. Nucleic Acids Res (2003) 1.36
The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med (2010) 1.36
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity. Traffic (2006) 1.36